EE570 A Swedish Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients With Inflammatory Bowel Disease
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.835
https://www.valueinhealthjournal.com/article/S1098-3015(23)03965-7/fulltext
Title :
EE570 A Swedish Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients With Inflammatory Bowel Disease
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03965-7&doi=10.1016/j.jval.2023.09.835
First page :
Section Title :
Open access? :
No
Section Order :
10325